Rutabaga Capital Management LLC Haemonetics Corp Transaction History

Rutabaga Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Apr 26, 2018	SELL	$60.72 - $74.41 $10.9 Million - $13.3 Million	-178,976 Closed	0 $0
Q4 2017 Feb 07, 2018	SELL	$44.96 - $58.99 $2.12 Million - $2.78 Million	-47,100 Reduced 20.83%	178,976 $10.4 Million
Q3 2017 Nov 13, 2017	SELL	$40.38 - $44.87 $8.77 Million - $9.75 Million	-217,193 Reduced 49.0%	226,076 $10.1 Million
Q2 2017 Aug 15, 2017	SELL	N/A	-75,218 Reduced 14.51%	443,269 $17.5 Million
Q3 2016 Jan 26, 2018	BUY	N/A	518,487	518,487 $18.8 Million

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.97B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Rutabaga Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Rutabaga Capital Management LLC with notifications on news.